Breakthrough pain is transitory pain that occurs despite the use of opioids for background pain control. Breakthrough pain occurs in 40% to 80% of patients with cancer pain. Despite effective analgesic therapy, patients and their caregivers often feel that their pain is not sufficiently controlled. Therefore, an improved understanding of breakthrough pain and its management is essential for all physicians caring for patients with cancer. This article reviews the definition, clinical manifestations, accurate diagnostic strategies, and optimal treatment options for breakthrough pain in patients with cancer. This review focuses on the efficacy and safety of rapid-onset opioids, which are the primary rescue drugs for breakthrough pain.
Citations
Citations to this article as recorded by
Validation of the Chinese Version Breakthrough Pain Assessment Tool in Cancer Patients Lin-Jiu Chen, Kun-Ming Rau, Pei-Chao Lin, Yi Liu, Pi-Ling Chou Pain Management Nursing.2026; 27(2): e207. CrossRef
Evaluating the Efficacy of Fentanyl Versus Diclofenac Sodium as Transdermal Patches in Controlling Post-operative Pain in Mandibular Third Molar Surgeries: A Prospective Comparative Study Swastik Hazra, Sapna Tandon, Hemant Mehra, Himanshu Chauhan, T. Adarsha, Dipanjan Chatterjee FACE.2026; 7(1): 103. CrossRef
Breakthrough cancer pain management (BTcP)—gap analysis of the current Australian landscape Wei Lee, Ahmed Nagla, Aaron Bak Ong Wong, Linda Magann, Melanie Lovell, Edward Mantle, Kate Reed, Ghauri Aggarwal, Aaron K. Wong, Chris Pene, Peter Allcroft, Gregory B. Crawford, Natasha Michael Supportive Care in Cancer.2026;[Epub] CrossRef
A Nurse-Led Multicomponent Self-Management Intervention for Patients With Cancer-Related Pain: A Randomized Controlled Trial Junfeng Zhang, Xing Wu, Wenru Yu, Shuzhen Zhang, Xinjie Xiang, Jiawen Chen, Yingying Cai, Laurie L.K. Ho, Dorothy N.S. Chan Pain Management Nursing.2026;[Epub] CrossRef
Opioids to Treat Chronic Pain in the Older Adult: A Clinical Consensus to Guarantee Safety and Avoid Adverse Events Hugo Ribeiro, João Rocha Neves, Paulo Roberto, Catarina Cunha Sousa, Diogo Barros, Joana Brandão Silva, Andreia Fernandes, Eduardo Dourado, Adriana Pereira, João Paulo Castro, Inês Rodrigues, Leonardo Napoleão, Mariana Fragão Marques, Marília Dourado, Jos Drugs & Aging.2026; 43(9): 817. CrossRef
Establishing an efficacy hierarchy for breakthrough cancer pain management: a network meta-analysis of rapid-onset fentanyl formulations and morphine Po-Hung Tsao, Cho-Hao Lee, Jia-Hong Chen, Ching-Liang Ho, Hong-Jie Jhou, Po-Huang Chen BMC Medicine.2026;[Epub] CrossRef
A scoping review of breakthrough cancer pain: Multidimensional patient needs and influencing factors Qingyi Li, Yanlei Sheng, Xinyu Liu, Jie Li, Lisi Zhu, Yang Yang, Luhong Hu Asia-Pacific Journal of Oncology Nursing.2025; 12: 100780. CrossRef
Pain is probably one of the most common cancer symptoms. In addition to being a major source of suffering and disability, cancer pain is extremely frightening for patients and their families. The authors propose to adjust the World Health Organization (WHO) pain management ladder from its current three-step approach to a more sophisticated five-step algorithm that includes physical and psychological modalities along the entire continuum of care and adds two more steps related to neuromodulative and neurodestructive procedures once the opioids fail. This review discusses the current surgical options for treating cancer pain, focusing on the continuous drug infusion pump currently available and briefly exploring some of the other surgical options for pain management. The introduction of intrathecal opioid administration for intractable cancer pain is considered as one of the most important breakthroughs in pain management. Morphine, the only opioid approved by FDA for intrathecal administration, has been increasingly utilized for this purpose.